The Native Antigen Company introduces new range of influenza antigens
Season-specific Haemagglutinin and Neuraminidase antigens will support vaccine and diagnostic reformulation programmes New range developed to cover 2023 southern hemisphere flu season Oxford, UK, 14 November 2022: The Native Antigen Company (part of LGC Clinical...
The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant
New antigens support research into BA.5 variant, currently responsible for over half of global COVID-19 cases Oxford, UK, 02 November 2022: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables...
The Native Antigen Company will be exhibiting at MEDICA
The Native Antigen Company will be exhibiting at MEDICA in Dϋsseldorf, Germany, 14-17 November at Hall 3 Booth 3H42 as part of the LGC Clinical Diagnostics Group. Please come and speak with one of our Experts at our booth. In line with the theme of this year’s event,...